Cooperative targeting of NF-κB enhances ferroptosis-driven HCC therapy with Alisertib and Donafenib

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC12380753 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature